Moreover, PLA2R1 promoter hypermethylation was found to be associated with aggressive subtypes of breast cancer, and PLA2R1 promoter hypermethylation was found to be a useful diagnostic and prognostic biomarker for breast cancer [17]. Here, PLA2R1 is linked to breast cancer.